ACCUVIX A30 VERSIONI: EX; EXCW; LV; LVCW Italia - italiano - Ministero della Salute

accuvix a30 versioni: ex; excw; lv; lvcw

samsung medison co ltd - ecotomografi multidisciplinari (internistici e cardiologici, ecc.)

SONO ACE R3 Italia - italiano - Ministero della Salute

sono ace r3

samsung medison co ltd - ecotomografi portatili

UGEO H60 Italia - italiano - Ministero della Salute

ugeo h60

samsung medison co ltd - ecotomografi multidisciplinari (internistici e cardiologici, ecc.)

MEDISON CAR 2 Italia - italiano - Ministero della Salute

medison car 2

eme srl - apparecchiature per terapia ad ultrasuoni

MEDISON CAR Italia - italiano - Ministero della Salute

medison car

eme srl - apparecchiature per terapia ad ultrasuoni

MEDISON 2 Italia - italiano - Ministero della Salute

medison 2

eme srl - apparecchiature per terapia ad ultrasuoni

MEDISON Italia - italiano - Ministero della Salute

medison

eme srl - apparecchiature per terapia ad ultrasuoni

Libtayo Unione Europea - italiano - EMA (European Medicines Agency)

libtayo

regeneron ireland designated activity company (dac) - cemiplimab - carcinoma, cellule squamose - agenti antineoplastici - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Kimmtrak Unione Europea - italiano - EMA (European Medicines Agency)

kimmtrak

immunocore ireland limited - tebentafusp - uveal neoplasms - agenti antineoplastici - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.

Vyvgart Unione Europea - italiano - EMA (European Medicines Agency)

vyvgart

argenx - efgartigimod alfa - myasthenia gravis - immunosoppressori - vyvgart is indicated as an add on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gmg) who are anti acetylcholine receptor (achr) antibody positive.